These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8240451)

  • 1. Effects of the combination of ketoconazole and calmodulin inhibitors against Candida albicans in vitro. Short communication.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Sep; 43(9):1018-9. PubMed ID: 8240451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticandidal activity of flunarizine.
    Krajewska-Kułak E; Niczyporuk WW
    Mater Med Pol; 1993; 25(3-4):143-4. PubMed ID: 8072319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activity in different media of ketoconazole, miconazole and amphotericin B against Candida lusitaniae and sucrose-negative Candida tropicalis.
    Mignini F; Prenna M; Oliveri S; Cammarata E; Falcioni E; Dainelli B; Ripa S
    Chemioterapia; 1988 Feb; 7(1):38-41. PubMed ID: 3378274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro sensitivity tests for yeasts: evaluation of a micromethod].
    Rodero LL; Davel GO; Vivot W; Canteros CE; Fernández C
    Rev Argent Microbiol; 1995; 27(2):81-9. PubMed ID: 8552761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activity of 2,5 disubstituted amino-oksometyloso-arylo-thiadiazole derivatives.
    Lukaszuk C; Krajewska-Kułak E; Niewiadomy A; Stachowicz J; Głaszcz U; Oksiejczuk E
    Adv Med Sci; 2007; 52 Suppl 1():26-9. PubMed ID: 18229628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of ketoconazole on human neutrophil chemotaxis and Candida albicans killing.
    Le Moli S; Seminara R; D'Amelio R; Pontesilli O; Nisini R
    Boll Ist Sieroter Milan; 1983; 62(6):531-4. PubMed ID: 6329246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans.
    Karasulu HY; Hilmioğlu S; Metin DY; Güneri T
    Farmaco; 2004 Feb; 59(2):163-7. PubMed ID: 14871509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The sensitivity to ketoconazole of Candida strains isolated from the digestive tract ontocenoses in children].
    Horwatt-Bozyczko E; Kurnatowski M; Wasowska-Królikowska K; Kurnatowska A
    Wiad Parazytol; 2001; 47(4):929-33. PubMed ID: 16886449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes.
    Shams-Ghahfarokhi M; Shokoohamiri MR; Amirrajab N; Moghadasi B; Ghajari A; Zeini F; Sadeghi G; Razzaghi-Abyaneh M
    Fitoterapia; 2006 Jun; 77(4):321-3. PubMed ID: 16690223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal activity of N-3-(1,2,4-dithiazole-5-thione)-beta-resorcylcarbothioamide.
    Niewiadomy A; Krajewska-Kułak E; Lukaszuk C; Matysiak J; Kostecka M
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():31-5. PubMed ID: 16119621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
    Bulatova NR; Darwish RM
    Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the in vitro activity of fluconazole against Candida albicans and dermatophytes.
    Wildfeuer A; Seidl HP
    Arzneimittelforschung; 1995 Jul; 45(7):819-21. PubMed ID: 8573230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoconazole/calix[n]arenes-based compounds improve the antifungal activity against azole-resistant Candida isolates.
    Spadari CC; Barreto TL; de Queiroz VT; de Paiva WF; Fernandes SA; de Fátima Â; Ishida K
    J Mycol Med; 2022 May; 32(2):101254. PubMed ID: 35168160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.